Share Twitter LinkedIn Facebook Email Earn CME: https://naccme.com/program/7313 In this presentation from the ‘New Horizons in the Treatment of Relapsed and Refractory Myeloma symposium, Dr. Jesús F. San Miguel discusses whether myeloma is curable. © 2018 Imedex, an HMP Company
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read